Yahoo Web Search

Search results

  1. Net income. £ (154.5) million (2023) [1] Website. nanoporetech.com. Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products (including the portable DNA sequencer, MinION) for the direct, electronic analysis of single molecules. [2][3][4]

  2. Gordon Sanghera is co-founder of Oxford Nanopore with Spike Willcocks and Hagan Bayley. He was appointed CEO in May 2005 and has led the company through multiple finance rounds, and in 2021, a listing on the London Stock Exchange. The company has developed a new generation of nanopore-based sensing technology.

  3. Jun 9, 2022 · Oxford Nanopore Technologies is not owned by hedge funds. IP Group Plc is currently the largest shareholder, with 11% of shares outstanding. For context, the second largest shareholder holds about ...

  4. Period. OXFORD NANOPORE TECHNOLOGIES LIMITED. 19 May 2008 - 24 Sep 2021. OXFORD NANOLABS LIMITED. 09 Mar 2005 - 19 May 2008. OXFORD NANOPORE TECHNOLOGIES PLC - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity.

  5. Jun 10, 2024 · Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition. ...

  6. About Oxford Nanopore. Oxford Nanopore was founded in 2005 to develop a disruptive, electronic, single-molecule sensing system based on nanopore science. The first product, MinION, was introduced into early access in 2014 and made commercially available in 2015. The scaled-up GridION was commercially launched in 2017 and PromethION in 2018 ...

  7. People also ask

  8. Jul 2, 2021 · Oxford Nanopore, one of Britain’s most highly valued tech start-ups, will use an “anti-takeover” structure in its upcoming IPO so it can fend off foreign bidders and become a national champion.

  1. People also search for